Pharmaceutical Products Companies By Short Ratio

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Short Ratio
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Short RatioEfficiencyMarket RiskExp Return
1DNTH Dianthus Therapeutics
22.17
(0.01)
 4.43 
(0.05)
2DSGN Design Therapeutics
17.3
(0.03)
 5.97 
(0.21)
3MLTX MoonLake Immunotherapeutics
14.49
(0.14)
 3.14 
(0.45)
4MNKD MannKind Corp
13.81
(0.12)
 2.38 
(0.29)
5NWBO Northwest Biotherapeutics
13.54
(0.02)
 3.65 
(0.06)
6MIRM Mirum Pharmaceuticals
13.0
 0.07 
 2.28 
 0.16 
7MNOV MediciNova
12.18
(0.06)
 3.48 
(0.22)
8MRUS Merus BV
11.9
 0.01 
 2.95 
 0.03 
9VERA Vera Therapeutics
10.97
(0.25)
 3.79 
(0.97)
10MDWD Mediwound
10.92
(0.01)
 3.51 
(0.02)
11UPB Upstream Bio,
10.79
(0.25)
 6.37 
(1.57)
12DVAX Dynavax Technologies
10.64
 0.07 
 1.20 
 0.08 
13OKUR OnKure Therapeutics,
10.28
(0.37)
 4.85 
(1.79)
14DRRX Durect
8.99
(0.01)
 5.45 
(0.05)
15MGNX MacroGenics
8.93
(0.15)
 3.55 
(0.53)
16MDGL Madrigal Pharmaceuticals
8.8
(0.01)
 3.42 
(0.04)
17VCEL Vericel Corp Ord
8.7
(0.08)
 2.05 
(0.15)
18MOLN Molecular Partners AG
8.25
(0.07)
 3.44 
(0.24)
19MCRB Seres Therapeutics
7.9
(0.06)
 4.82 
(0.29)
20VERV Verve Therapeutics
7.88
 0.07 
 7.12 
 0.48 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise. The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY